Literature DB >> 30808201

Galectin-3 is associated with arterial stiffness among hemodialysis patients.

Qi Zhang1,2, Kanhua Yin3, Mingli Zhu2, Xinghui Lin2, Yan Fang2, Jiayue Lu2, Zhenyuan Li2, Zhaohui Ni2.   

Abstract

Aim: To evaluate the association between galectin-3 and arterial stiffness among hemodialysis patients.
Methods: We enrolled 311 patients (median age: 61 years) with a median hemodialysis time of 90 months and a mean galectin-3 concentration of 29.78 ng/ml. Ninety-six (30.7%) had arterial stiffness diagnosed by the pulse-wave velocity over 10 m/s.
Results: Galectin-3 was significantly associated with dialysis vintage, calcium, phosphorus and low-density lipoprotein. After adjustment for multiple cardiovascular risk factors, galectin-3 was independently associated with the pulse-wave velocity (partial r = 0.130; p = 0.035). This effect was still significant after additional adjustment for mean arterial pressure and single-pool Kt/V (partial r = 0.139; p = 0.014).
Conclusion: Galectin-3 is independently associated with arterial stiffness among hemodialysis patients.

Entities:  

Keywords:  arterial stiffness; galectin-3; hemodialysis; pulse-wave velocity

Mesh:

Substances:

Year:  2019        PMID: 30808201     DOI: 10.2217/bmm-2018-0488

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  6 in total

1.  Investigation of the Relationship between Cardiovascular Biomarkers and Brachial-Ankle Pulse Wave Velocity in Hemodialysis Patients.

Authors:  Ping-Ruey Chou; Pei-Yu Wu; Ping-Hsun Wu; Teng-Hui Huang; Jiun-Chi Huang; Szu-Chia Chen; Su-Chu Lee; Mei-Chuan Kuo; Yi-Wen Chiu; Ya-Ling Hsu; Jer-Ming Chang; Shang-Jyh Hwang
Journal:  J Pers Med       Date:  2022-04-15

2.  Associations of Small Fiber Neuropathy with Geriatric Nutritional Risk Index and Arterial Stiffness in Hemodialysis.

Authors:  Mei-Chuan Kuo; Jiun-Chi Huang; Pei-Yu Wu; Hsiu-Chin Mai; Szu-Chia Chen; Yi-Wen Chiu; Jer-Ming Chang; Hung-Chun Chen
Journal:  Dis Markers       Date:  2020-05-19       Impact factor: 3.434

3.  Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension.

Authors:  Emily S Lau; Elizabeth Liu; Samantha M Paniagua; Amy A Sarma; Giovanna Zampierollo; Begoña López; Javier Díez; Thomas J Wang; Jennifer E Ho
Journal:  JACC Basic Transl Sci       Date:  2021-01-06

4.  Serum Galectin-3 Level Is Positively Associated with Endothelial Dysfunction in Patients with Chronic Kidney Disease Stage 3 to 5.

Authors:  Bang-Gee Hsu; Chih-Hsien Wang; Yu-Hsien Lai; Jen-Pi Tsai
Journal:  Toxins (Basel)       Date:  2021-07-29       Impact factor: 4.546

5.  Association between circulating Galectin-3 and arterial stiffness in older adults.

Authors:  Xiaoming Jia; Caroline Sun; Hirofumi Tanaka; Mahmoud Al Rifai; David Aguilar; Chiadi Ndumele; Elizabeth Selvin; Salim S Virani; Ron C Hoogeveen; Gerardo Heiss; Christie M Ballantyne; Vijay Nambi
Journal:  Vasa       Date:  2021-08-04       Impact factor: 1.961

6.  Combining Pulse Wave Velocity With Galectin-3 to Predict Mortality and Cerebrovascular and Cardiovascular Events in Hemodialysis Patients.

Authors:  Qi Zhang; Kanhua Yin; Mingli Zhu; Xinghui Lin; Yan Fang; Jiayue Lu; Zhenyuan Li; Zhaohui Ni
Journal:  Front Med (Lausanne)       Date:  2020-10-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.